Back to results
US 2021/0332373 A1Published application
E. coli-based production of beta-lactamase
AssigneeSynthetic Biologics, Inc.
InventorsAndrew BRISTOL, Michael KALEKO, Steven HUBERT
Life of this patent
Estimating the term…
Abstract
The invention relates to, in part, improved methods for the production of beta-lactamase using Escherichia coli (E. coli) cells. High yield production of beta-lactamase is achieved using methods of the invention.
Claims18
A method for the production of a beta-lactamase polypeptide in Escherichia coli (E. coli), comprising:
- (a) providing a host E. coli cell transformed with an expression vector comprising a sequence encoding the beta-lactamase polypeptide;
- (b) culturing the E. coli cell to induce expression of the beta-lactamase polypeptide in the cytoplasm;
- and
- (c) recovering the beta-lactamase polypeptide from a cytoplasmic soluble fraction prepared from the E. coli cell;
- and
- wherein the method yields more than 10 grams of the beta-lactamase polypeptide per liter of culture,
- wherein the beta-lactamase polypeptide is not recovered or purified from a periplasmic fraction, a cell envelope fraction, a cytoplasmic insoluble fraction, an inclusion body, or an extracellular fraction of the E. coli cell.
4 more elements
2-3. (canceled)
(canceled)
(canceled)
(canceled)
A method for the production of a beta-lactamase polypeptide in Escherichia coli (E. coli), comprising:
- (a) providing a host E. coli cell transformed with an expression vector comprising a sequence encoding the beta-lactamase polypeptide;
- (b) culturing the E. coli cell to induce expression of the beta-lactamase polypeptide in the cytoplasm;
- and
- (c) recovering the beta-lactamase polypeptide from a soluble fraction prepared from the E. coli cell;
- wherein:
- the method yields more than 15 grams of the beta-lactamase polypeptide per liter of culture;
- wherein the beta-lactamase polypeptide is not recovered or purified from a periplasmic fraction, a cell envelope fraction, a cytoplasmic insoluble fraction, an inclusion body, or an extracellular fraction of the E. coli cell.
4 more elements
Dependencies are inferred from the claim text.